Biogen’s statement on the SMC decision
Biogen's statement re. Scottish decision on nusinersen availability
Breaking news: Scotland refuses to treat majority of people with spinal muscular atrophy
Scotland annouces very restricted access to Spinraza, depriving the majority of SMA patients of an effective treatment
Australia will allocate $240 million to fund Spinraza treatment
Australia will allocate 240 million Australian dollars to fund the break-through Spinraza treatment for those with spinal muscular atrophy.
Update on Spinraza appraisal process
Below is an outline of the regulatory appraisal process of Spinraza in England and Wales.
New Standard of Care in SMA is published
A new Standard of Care in spinal muscular atrophy has been published.
Google blocks TreatSMA email system again
Google deprives TreatSMA of access to email and data again
Thank you, George’s Family!
TreatSMA would like to thank the Family of little fighter George for raising £2,750 in support of TreatSMA.